欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/2868/006
药品名称Augmentan Kindersaft
活性成分
    • Amoxicillin trihydrate 459.11 mg
    • Clavulanic acid 57.0 mg
剂型Powder for oral suspension
上市许可持有人GlaxoSmithKline GmbH & Co. KG Prinzregentenplatz 9 81675 München Germany
参考成员国 - 产品名称Germany (DE)
Augmentan Kindersaft
互认成员国 - 产品名称
    • Norway (NO)
    • Latvia (LV)
    • Czechia (CZ)
    • Croatia (HR)
    • Austria (AT)
    • Ireland (IE)
    • Liechtenstein (LI)
    • France (FR)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Poland (PL)
    • Estonia (EE)
    • Hungary (HU)
    • Bulgaria (BG)
    • Cyprus (CY)
    • Romania (RO)
    • Slovakia (SK)
    • Malta (MT)
许可日期2010/07/09
最近更新日期2025/02/11
药物ATC编码
    • J01CR02 amoxicillin and beta-lactamase inhibitor
申请类型
  • TypeLevel1:New Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase